◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › XOMA

XOMA Royalty Corporation (XOMA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-10

XOMA Royalty Corporation (XOMA) operates in the Biotechnology industry and is headquartered in EmeryVille, United States with about 14 employees. Its market capitalization is roughly $792 million. In the fiscal year ended 2025-12-31, XOMA reported $12M in revenue and $32M in net income.

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates.

Interactive charts & full statements → Open the XOMA valuation workbench →

XOMA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$12M$10M$5M$6M
Operating Income (EBIT)$11M($40M)($24M)($17M)
Net Income$32M($14M)($41M)($17M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XOMA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$1M$0M$5M$4M
Operating Income (EBIT)($0M)$2M($1M)$5M$6M
Net Income$4M$6M$14M$9M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XOMA Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid($6M)($6M)($6M)($6M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XOMA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid($1M)($1M)($1M)($1M)($1M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XOMA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$273M$221M$234M$140M
Total Liabilities$189M$159M$146M$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XOMA viewer.

Other Companies in Biotechnology

← XOMAll stocksXOS →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.